Result and key figures

Mehiläinen’s revenue for 2024 increased by 11.5 % from the previous year to EUR 2,063.5 (1,850.2) million. While growth was mainly organic, the company also completed business acquisitions.

– 2024 did not include any significant irregularities or surprises in terms of the external operating environment, and we were able to focus on the continuous improvement of the quality and efficiency of operations. We made significant investments, our revenue continued to increase, and we were also able to improve profitability from the previous year, says Janne-Olli Järvenpää, CEO of Mehiläinen Group.

Mehiläinen’s underlying operating profit before the depreciation of intangible assets generated by business acquisitions, impairment and items affecting comparability (underlying EBITA) was EUR 289.1 (215.7) million. The financial result for the year was EUR 39.2 (40.1) million, or approximately 1.9 % of revenue. Investments in facilities, digital development, medical devices, and other fixed assets grew by about 70.5% from the previous year and amounted to 69.8 (40.9) million euros. Investments, including acquisitions, increased to 192,3 (88,1) million euros.

Mehiläinen’s tax footprint increased to EUR 446.9 (389.4) million during the year. Corporate income taxes amounted to EUR 33.1 (22.6) million.

The Net Promoter Score (NPS), which measures the customer experience in private healthcare services, increased further to an all-time high level at 91.

Round key figures from 2024